Life ScienceCompany
ANI Pharmaceuticals has acquired 14 companies, including 8 in the last 5 years. A total of 1 acquisition came from private equity firms.
ANI Pharmaceuticals’ largest acquisition to date was in 2021, when it acquired Novitium Pharma for $164M. ANI Pharmaceuticals has acquired in 5 different US states, and 4 countries. The Company’s most targeted sectors include life science (86%) and medical products (15%).
Join Mergr and gain access to ANI Pharmaceuticals’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Summary
-
M&A Total Activity14
- M&A Buy Activity14
- Total Sectors Invested 2
- Total Countries Invested 4
- M&A Buy/Sell Connections 11
- M&A Advisors 6
Unlimited Searches
